Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04219397Not ApplicableCompleted

Investigating Interventions to Reduce Residual Opioids in the Home Following Legitimate Opioid Prescribing in Children.

Role: collaborator

NCT06148285Not ApplicableRecruiting

Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)

Role: lead

NCT02788591Not ApplicableTerminated

Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection

Role: lead

NCT04344444Phase 3Terminated

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

Role: lead

All 4 trials loaded